Last reviewed · How we verify
corticosteroid nasal irrigation
At a glance
| Generic name | corticosteroid nasal irrigation |
|---|---|
| Also known as | Budesonide nasal irrigation |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis (PHASE4)
- Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma (PHASE3)
- Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) (PHASE4)
- 3D Printing to Improve Nasal Irrigation Outcome (NA)
- Budesonide Irrigation in Allergic Rhinitis (PHASE4)
- Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)
- The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life
- Longitudinal Preschool Wheeze Biomarker Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: